Our laboratory and others have reported that Brattleboro (BRAT) rats, a Long Evans (LE) strain with a single gene mutation, have inherent deficits in prepulse inhibition (PPI) homologous to those observed in schizophrenia patients and that these deficits are reversed by antipsychotic drugs (APDs). To further evaluate the potential predictive validity of BRAT rat PPI for APDs, we compared the effects of acute subcutaneous administration of the typical APD chlorpromazine to that of three psychotropic drugs without antipsychotic efficacy, the antidepressant imipramine, the anxiolytic diazepam and the anticonvulsant mood stabilizer valproic acid on male and female BRAT rat PPI. Male and female BRAT rats exhibited baseline (saline treatment) PPI that was not different from each other (21.1% and 21.3%, respectively) and low compared with those historically exhibited by LE rats (approximately 59%). Chlorpromazine facilitated PPI in male and female BRAT rats, whereas imipramine, diazepam, and valproic acid had no significant effect on PPI. These results suggest that PPI in the BRAT rat responds specifically to drugs with APD efficacy but not psychotropic drugs of different therapeutic families.
BeckerHCAntonRF (1990) Valproate potentiates and picrotoxin antagonizes the anxiolytic action of ethanol in a nonshock conflict task. Neuropharmacology29: 837–843.
2.
BirkettSDPickeringBT (1988) The vasopressin precursor in the Brattleboro (di/di) rat. Int J Peptide Protein Res32: 565–572.
3.
BohusBde WiedD (1998) The vasopressin deficient Brattleboro rats: a natural knockout model used in the search for CNS effects of vasopressin. Prog Brain Res119: 555–573.
4.
CiliaJGartlonJEShilliamCDawsonLAMooreSHJonesDN (2010) Further neurochemical and behavioural investigation of Brattleboro rats as a putative model of schizophrenia. J Psychopharmacol24: 407–419.
5.
CiliaJReavillCHaganJJJonesDN (2001) Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats. Psychopharmacology (Berl)156: 327–337.
6.
de JongTRSnaphaanLJPattijT (2006) Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats. Eur Neuropsychopharmacol16: 39–48.
7.
DochertyNMGordinierSW (1999) Immediate memory, attention and communication disturbances in schizophrenia patients and their relatives. Psychological Medicine29(1): 189–197.
8.
DuncanGEMoySSLiebermanJAKollerBH (2006) Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function. Psychopharmacology (Berl)184: 190–200.
9.
FeifelDMelendezGPriebeKShillingPD (2007) The effects of chronic administration of established and putative antipsychotics on natural prepulse inhibition deficits in Brattleboro rats. Behav Brain Res181: 278–286.
10.
FeifelDMelendezGShillingPD (2004) Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: a potential predictive model for novel antipsychotic effects. Neuropsychopharmacology29: 731–738.
11.
FeifelDMexalSMelendezGLiuPYGoldenbergJRShillingPD (2009) The Brattleboro rat displays a natural deficit in social discrimination that is restored by clozapine and a neurotensin analog. Neuropsychopharmacology34: 2011–2018.
12.
FeifelDPriebeK (2001) Vasopressin-deficient rats exhibit sensorimotor gating deficits that are reversed by subchronic haloperidol. Biol Psychiatry50: 425–433.
GeyerMAKrebs-ThomsonKBraffDLSwerdlowNR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl)156: 117–154.
15.
GeyerMAWilkinsonLSHumbyTRobbinsTW (1993) Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia. Biol Psych34: 361–372.
16.
HammerTBOranjeBGlenthojBY (2007) The effects of imipramine on P50 suppression, prepulse inhibition and habituation of the startle response in humans. Int J Neuropsychopharmacol10: 787–795.
17.
KestlerLPWalkerEVegaEM (2001) Dopamine receptors in the brains of schizophrenia patients: a meta-analysis of the findings. Behav Pharmacol12: 355–371.
18.
KumariVSharmaT (2002) Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research. Psychopharmacology (Berl)162: 97–101.
19.
Le PenGMoreauJL (2002) Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology27: 1–11.
20.
LipskaBKSwerdlowNRGeyerMAJaskiwGEBraffDLWeinbergerDR (1995) Neonatal excitotoxic hippocampal damage in rats causes post‐pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology122: 35–43.
21.
MallaAK (1995) Negative symptoms and affective disturbance in schizophrenia and related disorders. Can J Psych Rev Can Psych40(7 Suppl 2): S55–S59.
22.
MansbachRS (1991) Effects of NMDA receptor ligands on sensorimotor gating in the rat. Eur J Pharmacol202: 61–66.
23.
MansbachRSGeyerMABraffDL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology94: 507–514.
24.
OngJCBrodySALargeCHGeyerMA (2005) An investigation of the efficacy of mood stabilizers in rodent models of prepulse inhibition. J Pharmacol Exp Ther315: 1163–1171.
25.
OranjeBKahnRSKemnerCVerbatenMN (2004) Modulating sensorimotor gating in healthy volunteers: the effects of desipramine and haloperidol. Psychiatry Res127: 195–205.
26.
OuagazzalAMJenckFMoreauJL (2001) Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity?Psychopharmacology (Berl)156: 273–283.
27.
PhillipsMLDavidAS (1995) Facial processing in schizophrenia and delusional misidentification: cognitive neuropsychiatric approaches. Schizophrenia Research17: 109–114.
28.
PouzetBAndersenMPHoggS (2005) Effects of acute treatment with antidepressant drugs on sensorimotor gating deficits in rats. Psychopharmacology (Berl)178: 9–16.
29.
RigdonGCViikK (1991) Prepulse inhibition as a screening test for potential antipsychotics. Drug Dev Res23: 91–99.
30.
RocheMShanahanEHarkinAKellyJP (2008) Trans-species assessment of antidepressant activity in a rodent model of depression. Pharmacol Rep60: 404–408.
31.
ShillingPDKinkeadBMurrayTMelendezGNemeroffCBFeifelD (2006) Upregulation of striatal dopamine-2 receptors in Brattleboro rats with prepulse inhibition deficits. Biol Psychiatry60: 1278–1281.
32.
SipesTAGeyerMA (1994) Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology33: 441–448.
33.
SwerdlowNRGeyerMA (1998) Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull24: 285–301.
34.
UmedaKSuemaruKTodoN (2006) Effects of mood stabilizers on the disruption of prepulse inhibition induced by apomorphine or dizocilpine in mice. Eur J Pharmacol553: 157–162.
35.
VartyGBHigginsGA (1995) Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs. Psychopharmacology122: 15–26.
36.
WeissICFeldonJDomeneyAM (1999) Circadian time does not modify the prepulse inhibition response or its attenuation by apomorphine. Pharmacol Biochem Behav64: 501–505.
37.
WilliamsARCareyRJMillerM (1983) Behavioral differences between vasopressin-deficient (Brattleboro) and normal Long-Evans rats. Peptides4: 711–716.
38.
YamadaSHaranoMAnnohNNakamuraKTanakaM (1999) Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats. Biol Psych46: 832–838.
